Dr. Lee has 30 years of experience representing companies in intellectual property matters. As an experienced chemist, Dr. Lee is adept at advising companies in the pharmaceutical, biotechnology, chemical and bioinformatics industries in all areas of patents, including litigation, interferences, counseling, and prosecution.
Dr. Lee brings his technical acuity to bear in a wide range of client matters. His patent litigation experience literally extends to products ranging from A to Z: generic versions of Allegra, Augmentin, Claritin, Gemzar, Hytrin, Neurontin, Oxycontin, Paxil, Procardia, Relafen, Sarafem, Seldane, Ticlid, Zantac and Zithromax; brand name pharmaceuticals including Duracef, Kadian, Lovenox, Ortho-Cyclen and Xalatan; as well as monoclonal antibodies for septic shock and against stem cells. Equally adept at representing clients whose innovations involve patents on bioinformatics and alternative methods for drug delivery, Dr. Lee has litigated cases involving DNA synthesis machines and transdermal drug delivery systems.
Dr. Lee’s experience gained while practicing chemistry for 11 years, including teaching as an associate professor of Chemistry at Fordham University, has enabled him to develop sophisticated litigation strategies for clients engaged in chemical related litigations involving coatings for aluminum cans, paints for automobiles and striped toothpaste. Dr. Lee also prosecutes patent applications in the chemical and life sciences areas, counsels inventors and patent owners on the scope and validity of their intellectual properties, and advises clients introducing new products and services as to any potential for infringement of the patent rights of others.
Dr. Lee has frequently been invited to speak at conferences around the world on topics pertaining to intellectual property law and litigation. He has often spoken at Fordham University’s School of Law Conference on International IP Law and Policy. He has also spoken at American Conference Institute’s Annual Paragraph IV Disputes and Maximizing Pharmaceutical Patent Life Cycles conferences; at a webinar hosted by the Intellectual Property Owners Association, a seminar hosted by the Fordham IP Institute, a seminar focused on “Navigating the Challenges of ANDA Disputes” during the Law360 Expert Insight Series, the New York Biotechnology Association’s Annual Meetings, the Institute for International Research’s Annual Generics Summit, a Pharmaceutical Law 2006 seminar entitled “Across the Product Life Cycle” hosted by the Practicing Law Institute, and GphA’s Annual Policy Conference: The Generic Industry Event of the Season.